Table 13 The cost-effectiveness analysis in the 12-month intervention period (the incidence of diabetes)
Group | C (yuan) | E (%) | C/E | ΔC/ΔE |
|---|---|---|---|---|
The treatment group | 21156020.3 | 16.5 | 1282183.0 | −188775.1 |
The control group | 18815209.0 | 28.9 | 651045.3 |
Group | C (yuan) | E (%) | C/E | ΔC/ΔE |
|---|---|---|---|---|
The treatment group | 21156020.3 | 16.5 | 1282183.0 | −188775.1 |
The control group | 18815209.0 | 28.9 | 651045.3 |
Trials